Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) saw strong trading volume on Wednesday . 4,541,314 shares changed hands during trading, an increase of 36% from the previous session's volume of 3,346,029 shares.The stock last traded at $15.44 and had previously closed at $15.28.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on OSCR. Bank of America cut Oscar Health from a "neutral" rating to an "underperform" rating and dropped their price target for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Jefferies Financial Group started coverage on Oscar Health in a research report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $21.56.
Read Our Latest Analysis on OSCR
Oscar Health Stock Performance
The firm has a market cap of $3.65 billion, a P/E ratio of -246.21, a PEG ratio of 0.67 and a beta of 1.73. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock's 50-day moving average is $15.14 and its 200 day moving average is $16.83.
Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. On average, research analysts predict that Oscar Health, Inc. will post -0.01 earnings per share for the current year.
Insider Activity at Oscar Health
In other Oscar Health news, Vice Chairman Joshua Kushner acquired 276,040 shares of the company's stock in a transaction that occurred on Monday, November 11th. The stock was acquired at an average cost of $13.58 per share, for a total transaction of $3,748,623.20. Following the transaction, the insider now directly owns 5,031,262 shares in the company, valued at $68,324,537.96. This represents a 5.80 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Steven Wolin sold 19,580 shares of the company's stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $354,006.40. Following the transaction, the chief operating officer now owns 102,598 shares of the company's stock, valued at $1,854,971.84. This trade represents a 16.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have purchased 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of the stock. KBC Group NV raised its holdings in shares of Oscar Health by 41.2% in the 3rd quarter. KBC Group NV now owns 4,552 shares of the company's stock worth $97,000 after purchasing an additional 1,328 shares during the period. Optimum Investment Advisors bought a new stake in Oscar Health during the third quarter valued at $142,000. ORG Wealth Partners LLC bought a new position in shares of Oscar Health in the fourth quarter worth approximately $100,000. Aigen Investment Management LP bought a new stake in shares of Oscar Health during the 3rd quarter worth $205,000. Finally, Alberta Investment Management Corp purchased a new position in shares of Oscar Health in the 4th quarter worth about $138,000. 75.70% of the stock is owned by institutional investors.
About Oscar Health
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Articles
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
